Company has shifted Chemical and Formulation Development (PTD) Research Centres from Jogeshwari to the new research facility called “Centre of Excellence [CoE]” in Goa. All R&D activities such as API chemical synthesis, Formulation Dosage Form development and Analytical Research are housed under one roof. Its location, in the same premises as the company’s Goa pharmaceutical plant, ensures that technology transfer, testing and roll-out of new products and processes is seamless.
PTDC’s major thrust area is in the development of generic formulations comprising Immediate Release as well as Novel Drug Delivery Systems (NDDS) and Abbreviated New Drug Applications (ANDAs) for the international market. The facility has been equipped to handle the development of formulations for New Chemical Entities (NCEs).
The PTDC facility has a team of highly result-oriented scientists leading the research efforts with expertise in a wide range of areas including NCEs. It is a self-contained product development laboratory that meets current Good Manufacturing Practice (cGMP) requirements. It is fully equipped to conduct pre-formulation studies, prototype development, scale-up & optimization and technology transfer of oral solid dosage forms.
The developmental activities are supported by a proficient Analytical Research Development team and a well-equipped laboratory,
In addition, the PTDC has the capability to develop a platform technology whereby different molecules can be processed for their controlled rate of release.
With an ideal synergy of high-end technology and superior expertise, PTDC is set to play a pivotal role in Unichem’s R&D efforts.